• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗效力估计的可推广性:对美国13价肺炎球菌结合疫苗上市后评估中纳入病例的分析。

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA.

作者信息

Link-Gelles Ruth, Westreich Daniel, Aiello Allison E, Shang Nong, Weber David J, Rosen Jennifer B, Motala Tasneem, Mascola Laurene, Eason Jeffery, Scherzinger Karen, Holtzman Corinne, Reingold Arthur L, Barnes Meghan, Petit Susan, Farley Monica M, Harrison Lee H, Zansky Shelley, Thomas Ann, Schaffner William, McGee Lesley, Whitney Cynthia G, Moore Matthew R

机构信息

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

出版信息

BMJ Open. 2017 Aug 28;7(8):e017715. doi: 10.1136/bmjopen-2017-017715.

DOI:10.1136/bmjopen-2017-017715
PMID:28851801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5724195/
Abstract

OBJECTIVES

External validity, or generalisability, is the measure of how well results from a study pertain to individuals in the target population. We assessed generalisability, with respect to socioeconomic status, of estimates from a matched case-control study of 13-valent pneumococcal conjugate vaccine effectiveness for the prevention of invasive pneumococcal disease in children in the USA.

DESIGN

Matched case-control study.

SETTING

Thirteen active surveillance sites for invasive pneumococcal disease in the USA.

PARTICIPANTS

Cases were identified from active surveillance and controls were age and zip code matched.

OUTCOME MEASURES

Socioeconomic status was assessed at the individual level via parent interview (for enrolled individuals only) and birth certificate data (for both enrolled and unenrolled individuals) and at the neighbourhood level by geocoding to the census tract (for both enrolled and unenrolled individuals). Prediction models were used to determine if socioeconomic status was associated with enrolment.

RESULTS

We enrolled 54.6% of 1211 eligible cases and found a trend toward enrolled cases being more affluent than unenrolled cases. Enrolled cases were slightly more likely to have private insurance at birth (p=0.08) and have mothers with at least some college education (p<0.01). Enrolled cases also tended to come from more affluent census tracts. Despite these differences, our best predictive model for enrolment yielded a concordance statistic of only 0.703, indicating mediocre predictive value. Variables retained in the final model were assessed for effect measure modification, and none were found to be significant modifiers of vaccine effectiveness.

CONCLUSIONS

We conclude that although enrolled cases are somewhat more affluent than unenrolled cases, our estimates are externally valid with respect to socioeconomic status. Our analysis provides evidence that this study design can yield valid estimates and the assessing generalisability of observational data is feasible, even when unenrolled individuals cannot be contacted.

摘要

目的

外部效度,即普遍性,是衡量一项研究结果与目标人群中的个体的契合程度的指标。我们评估了一项针对美国儿童13价肺炎球菌结合疫苗预防侵袭性肺炎球菌疾病有效性的匹配病例对照研究中,估计值在社会经济地位方面的普遍性。

设计

匹配病例对照研究。

地点

美国13个侵袭性肺炎球菌疾病的主动监测点。

参与者

病例通过主动监测确定,对照按年龄和邮政编码匹配。

结局指标

通过家长访谈(仅针对已登记个体)和出生证明数据(针对已登记和未登记个体)在个体层面评估社会经济地位,并通过地理编码到普查区在邻里层面评估(针对已登记和未登记个体)。使用预测模型来确定社会经济地位是否与登记有关。

结果

我们纳入了1211例 eligible 病例中的54.6%,发现已登记病例比未登记病例更富裕的趋势。已登记病例在出生时更有可能拥有私人保险(p = 0.08),且母亲至少有一些大学教育程度的可能性更高(p < 0.01)。已登记病例也往往来自更富裕的普查区。尽管存在这些差异,我们用于登记的最佳预测模型的一致性统计量仅为0.703,表明预测价值一般。对最终模型中保留的变量进行了效应测量修正评估,未发现有变量是疫苗有效性的显著修正因素。

结论

我们得出结论,尽管已登记病例比未登记病例在一定程度上更富裕,但我们的估计在社会经济地位方面具有外部效度。我们的分析提供了证据,表明这种研究设计可以产生有效的估计值,并且即使无法联系到未登记个体,评估观察数据的普遍性也是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1769/5724195/7d9a09950210/bmjopen-2017-017715f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1769/5724195/7d9a09950210/bmjopen-2017-017715f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1769/5724195/7d9a09950210/bmjopen-2017-017715f01.jpg

相似文献

1
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA.疫苗效力估计的可推广性:对美国13价肺炎球菌结合疫苗上市后评估中纳入病例的分析。
BMJ Open. 2017 Aug 28;7(8):e017715. doi: 10.1136/bmjopen-2017-017715.
2
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.13 价肺炎球菌结合疫苗预防美国儿童侵袭性肺炎球菌病的效果:一项匹配病例对照研究。
Lancet Respir Med. 2016 May;4(5):399-406. doi: 10.1016/S2213-2600(16)00052-7. Epub 2016 Mar 14.
3
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.13 价肺炎球菌结合疫苗在南非儿童侵袭性肺炎球菌病中的有效性:病例对照研究。
Lancet Glob Health. 2017 Mar;5(3):e359-e369. doi: 10.1016/S2214-109X(17)30043-8. Epub 2017 Jan 28.
4
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.七价肺炎球菌结合疫苗预防侵袭性肺炎球菌疾病的有效性:一项配对病例对照研究。
Lancet. 2006 Oct 28;368(9546):1495-502. doi: 10.1016/S0140-6736(06)69637-2.
5
Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.7 价肺炎球菌结合疫苗在预防 7-59 月龄儿童侵袭性肺炎球菌病中的有效性。一项匹配病例对照研究。
Vaccine. 2011 Nov 8;29(48):9020-5. doi: 10.1016/j.vaccine.2011.09.034. Epub 2011 Sep 20.
6
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.十价肺炎球菌结合疫苗(PHiD-CV10)对侵袭性肺炎球菌病的有效性:一项集群随机试验。
Lancet. 2013 Jan 19;381(9862):214-22. doi: 10.1016/S0140-6736(12)61854-6. Epub 2012 Nov 16.
7
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.澳大利亚 2002-2014 年 7 价和 13 价肺炎球菌结合疫苗“3+0”免疫程序对侵袭性肺炎球菌病的长期影响
Clin Infect Dis. 2017 Jan 15;64(2):175-183. doi: 10.1093/cid/ciw720. Epub 2016 Oct 21.
8
Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study.台湾地区不同价次肺炎球菌结合疫苗对儿童侵袭性肺炎球菌疾病的有效性:一项全国性研究
Pediatr Infect Dis J. 2016 Apr;35(4):e124-33. doi: 10.1097/INF.0000000000001054.
9
Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.肺炎球菌性流感嗜血杆菌蛋白 D 结合疫苗(PHiD-CV10)对临床疑似侵袭性肺炎球菌病的疫苗效力:一项集群随机试验。
Lancet Respir Med. 2014 Sep;2(9):717-27. doi: 10.1016/S2213-2600(14)70139-0. Epub 2014 Aug 7.
10
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.对2000年至2005年期间接种7价肺炎球菌结合疫苗的儿童群体进行侵袭性肺炎球菌疾病监测。
Pediatr Infect Dis J. 2007 Sep;26(9):771-7. doi: 10.1097/INF.0b013e318124a494.

引用本文的文献

1
Rising Pneumococcal Antibiotic Resistance in the Post-13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting.13 价肺炎球菌结合疫苗时代后,基层医疗机构分离的儿童肺炎链球菌对常用抗生素的耐药性上升。
Clin Infect Dis. 2021 Mar 1;72(5):797-805. doi: 10.1093/cid/ciaa157.

本文引用的文献

1
Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study.社会经济地位方面的偏差:深入研究肺炎球菌疫苗有效性研究中的邮政编码匹配情况。
SSM Popul Health. 2016 Dec;2:587-594. doi: 10.1016/j.ssmph.2016.08.005.
2
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.13 价肺炎球菌结合疫苗预防美国儿童侵袭性肺炎球菌病的效果:一项匹配病例对照研究。
Lancet Respir Med. 2016 May;4(5):399-406. doi: 10.1016/S2213-2600(16)00052-7. Epub 2016 Mar 14.
3
Advancing research on racial-ethnic health disparities: improving measurement equivalence in studies with diverse samples.
推进种族和民族健康差异研究:改善具有不同样本的研究中的测量等效性。
Front Public Health. 2014 Dec 22;2:282. doi: 10.3389/fpubh.2014.00282. eCollection 2014.
4
The use of propensity scores to assess the generalizability of results from randomized trials.使用倾向评分评估随机试验结果的可推广性。
J R Stat Soc Ser A Stat Soc. 2001 Apr 1;174(2):369-386. doi: 10.1111/j.1467-985X.2010.00673.x.
5
Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.2013-14 年季节性流感疫苗效力的临时估计 - 美国,2014 年 2 月。
MMWR Morb Mortal Wkly Rep. 2014 Feb 21;63(7):137-42.
6
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.随机对照试验与基于人群的观察性研究:医学证据发展中的合作伙伴。
Br J Cancer. 2014 Feb 4;110(3):551-5. doi: 10.1038/bjc.2013.725. Epub 2014 Jan 14.
7
Understanding why patients of low socioeconomic status prefer hospitals over ambulatory care.理解为什么社会经济地位较低的患者更喜欢选择医院而不是门诊护理。
Health Aff (Millwood). 2013 Jul;32(7):1196-203. doi: 10.1377/hlthaff.2012.0825.
8
The role of the c-statistic in variable selection for propensity score models.C 统计量在倾向评分模型变量选择中的作用。
Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):317-20. doi: 10.1002/pds.2074. Epub 2010 Dec 9.
9
Analyzing marginal cases in differential shotgun proteomics.分析差异 shotgun 蛋白质组学中的边缘案例。
Bioinformatics. 2011 Jan 15;27(2):275-6. doi: 10.1093/bioinformatics/btq632. Epub 2010 Nov 11.
10
Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.将随机临床试验证据推广到目标人群:ACTG 320 试验。
Am J Epidemiol. 2010 Jul 1;172(1):107-15. doi: 10.1093/aje/kwq084. Epub 2010 Jun 14.